Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
- PMID: 384241
- DOI: 10.1056/NEJM197909273011303
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
Abstract
One hundred and fifty patients with advanced cancer participated in a controlled double-blind study to evaluate the effects of high-dose vitamin C on symptoms and survival. Patients were divided randomly into a group that received vitamin C (10 g per day) and one that received a comparably flavored lactose placebo. Sixty evaluable patients received vitamin C and 63 received a placebo. Both groups were similar in age, sex, site of primary tumor, performance score, tumor grade and previous chemotherapy. The two groups showed no appreciable difference in changes in symptoms, performance status, appetite or weight. The median survival for all patients was about seven weeks, and the survival curves essentially overlapped. In this selected group of patients, we were unable to show a therapeutic benefit of high-dose vitamin C treatment.
Similar articles
-
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.N Engl J Med. 1985 Jan 17;312(3):137-41. doi: 10.1056/NEJM198501173120301. N Engl J Med. 1985. PMID: 3880867 Clinical Trial.
-
Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study.Eur J Obstet Gynecol Reprod Biol. 2004 Nov 10;117(1):70-5. doi: 10.1016/j.ejogrb.2004.02.032. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15474248 Clinical Trial.
-
Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis.N Engl J Med. 1979 Apr 5;300(14):756-9. doi: 10.1056/NEJM197904053001403. N Engl J Med. 1979. PMID: 370586 Clinical Trial.
-
High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.Anticancer Res. 2009 Mar;29(3):809-15. Anticancer Res. 2009. PMID: 19414313 Review.
-
Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?P R Health Sci J. 2010 Sep;29(3):215-7. P R Health Sci J. 2010. PMID: 20799507 Review.
Cited by
-
Vitamin and mineral supplements: do we really need them?Int J Prev Med. 2012 Mar;3(3):221-6. Int J Prev Med. 2012. PMID: 22448315 Free PMC article.
-
Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy.Int J Gen Med. 2009 Jul 30;2:91-108. doi: 10.2147/ijgm.s5498. Int J Gen Med. 2009. PMID: 20360893 Free PMC article.
-
Reconvene and reconnect the antioxidant hypothesis in human health and disease.Indian J Clin Biochem. 2010 Jul;25(3):225-43. doi: 10.1007/s12291-010-0078-y. Epub 2010 Sep 3. Indian J Clin Biochem. 2010. PMID: 21731194 Free PMC article.
-
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?Nat Rev Cancer. 2014 Nov;14(11):709-21. doi: 10.1038/nrc3803. Nat Rev Cancer. 2014. PMID: 25342630 Free PMC article. Review.
-
The Influence of High-Dose Parenteral Vitamin C on the Incidence and Severity of Postoperative Pulmonary Complications in Cardiac Surgery with Extracorporeal Circulation: A Randomized Controlled Trial.Nutrients. 2024 Mar 7;16(6):761. doi: 10.3390/nu16060761. Nutrients. 2024. PMID: 38542673 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources